• No results found

University of Groningen Long-term cardiovascular effects of breast cancer treatment Boerman, Liselotte

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Long-term cardiovascular effects of breast cancer treatment Boerman, Liselotte"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Long-term cardiovascular effects of breast cancer treatment

Boerman, Liselotte

DOI:

10.33612/diss.116880323

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Boerman, L. (2020). Long-term cardiovascular effects of breast cancer treatment. University of Groningen. https://doi.org/10.33612/diss.116880323

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)







‘‰Ǧ–‡”…ƒ”†‹‘˜ƒ•…—Žƒ”‡ˆˆ‡…–•

‘ˆ„”‡ƒ•–…ƒ…‡”–”‡ƒ–‡–



















(3)

2

The work described in this thesis was conducted at the Department of General Practice and department of Epidemiology, University of Groningen, University Medical Center Groningen, The Netherlands

The study described in this thesis was funded by a grant from Pink Ribbon and stichting De Friesland.

Publication of this thesis was financially supported by SHARE, RUG and UMCG © Copyright 2020 L.M. Boerman, The Netherlands

All rights reserved. No part of this thesis may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, without the written permission of the author or, when appropriate, of the publishers of the publications.

Cover design: A. Polgar Printed by: Ridderprint

ISBN 978-94-034-2230-5 (printed version) ISBN 978-94-034-2229-9 (electronic version)

Proefschrift

Liselotte Mirjam Boerman

(4)

   





‘‰Ǧ–‡”…ƒ”†‹‘˜ƒ•…—Žƒ”‡ˆˆ‡…–•

‘ˆ„”‡ƒ•–…ƒ…‡”–”‡ƒ–‡–

    

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. C. Wijmenga en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 12 februari 2020 om 11.00 uur

   

door

Liselotte Mirjam Boerman

geboren op 19 april 1989 te Leiden

(5)

4

Promotores

Prof. dr. G.H. de Bock Prof. dr. M.Y. Berger C Copromotor Dr. A.J. Berendsen Beoordelingscommissie Prof. dr. J.J. Assendelft Prof. dr. J.A. Langendijk Prof. dr. A.H.E.M. Maas

Paranimfen

(6)

Promotores Copromotor Beoordelingscommissie Paranimfen Dr. C.M.G. van Driel Mw. J.A. Barentsen

(7)

6

(8)

Chapter 1



General Introduction p. 9 Part I: Long--term prevalence of cardiovvascular disease and cardiac dysfunction

Chapter 2 Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population

p. 19

Chapter 3 Long-term outcome of cardiac function in a population-based cohort of early breast cancer survivors: a cross-sectional study

p. 35

Part II: Risk assessment

Chapter 4 Troponin and (NT-pro)BNP as predictors for the occurrence of asymptomatic and symptomatic cardiac dysfunction during or after breast cancer treatment: a systematic review

p. 57

Chapter 5 Long-term survivors of breast cancer treated with chemotherapy are characterized by a pro-inflammatory biomarker profile compared to matched controls

p. 79

Chapter 6 Summary, general discussion and recommendations p. 99

Chapter 7 Nederlandse samenvatting p. 113

Appendices References p. 121

Dankwoord p. 145

Curriculum Vitae p. 151 Lijst deelnemende praktijken p. 155

Research Institute SHARE p. 159

(9)

8

Referenties

GERELATEERDE DOCUMENTEN

41 Therefore, we assessed the prevalence of long-term echocardiographic-based cardiac dysfunction among breast cancer survivors treated with chemotherapy (± radiotherapy)

Given that troponin, BNP or NT-proBNP levels may increase due to the cardiotoxic effects of chemotherapy and radiotherapy, they may be used as biomarkers to identify patients

Particularly, a number of biomarkers including PCSK9, CXCL16 and MCP1 were higher in survivors previously treated with aromatase inhibitors, suggesting that the possible

In this thesis, we have shown that long-term breast cancer survivors treated with chemo- and/or radiotherapy have a twice as high risk of developing mild systolic cardiac

Om het vóórkomen van eventuele hart- en vaatziekten in deze groep vrouwen te kunnen vaststellen, hebben wij de uitkomsten vergeleken met 350 vrouwen van dezelfde leeftijd

Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients.. Int J Radiat Oncol

To our knowledge this is the first study of its kind in an unselected population of patients from general practice with breast cancer, to assess the risk of CVD among women

Vrouwen met borstkanker die in het verleden zijn behandeld met chemotherapie (met of zonder radiotherapie) hebben een grotere kans op het krijgen van hartvaatziekten